Interleukin-6 “Trans-Signaling” and Ischemic Vascular Disease: The Important Role of Soluble gp130
出版年份 2017 全文链接
标题
Interleukin-6 “Trans-Signaling” and Ischemic Vascular Disease: The Important Role of Soluble gp130
作者
关键词
-
出版物
MEDIATORS OF INFLAMMATION
Volume 2017, Issue -, Pages 1-6
出版商
Hindawi Limited
发表日期
2017-02-01
DOI
10.1155/2017/1396398
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Soluble Glycoprotein 130 and Heat Shock Protein 27 as Novel Candidate Biomarkers of Chronic Heart Failure with Preserved Ejection Fraction
- (2016) Shengchen Liu et al. Heart Lung and Circulation
- Circulating Levels of IL‐6 Receptor and gp130 and Long‐Term Clinical Outcomes in ST‐Elevation Myocardial Infarction
- (2016) Vibeke N. Ritschel et al. Journal of the American Heart Association
- Circulating levels of interleukin 6 soluble receptor and its natural antagonist, sgp130, and the risk of myocardial infarction
- (2015) Ilais Moreno Velásquez et al. ATHEROSCLEROSIS
- Blocking IL-6 trans-Signaling Prevents High-Fat Diet-Induced Adipose Tissue Macrophage Recruitment but Does Not Improve Insulin Resistance
- (2015) Michael J. Kraakman et al. Cell Metabolism
- The IL-6/gp130/STAT3 signaling axis: recent advances towards specific inhibition
- (2015) Christoph Garbers et al. CURRENT OPINION IN IMMUNOLOGY
- Inflammation-Induced IL-6 Functions as a Natural Brake on Macrophages and Limits GN
- (2015) M. Luig et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Insulin resistance and systemic inflammation, but not metabolic syndrome phenotype, predict 9 years mortality in older adults
- (2014) Giovanni Zuliani et al. ATHEROSCLEROSIS
- The interleukin-6 receptor Asp358Ala single nucleotide polymorphism rs2228145 confers increased proteolytic conversion rates by ADAM proteases
- (2014) Christoph Garbers et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Inflammation and Atherosclerosis
- (2014) Joshua Hartman et al. Cardiology in Review
- Interleukin-6 and its receptors: A highly regulated and dynamic system
- (2014) Janina Wolf et al. CYTOKINE
- The good, the bad, and the ugly of interleukin-6 signaling
- (2014) J. J. Fuster et al. EMBO JOURNAL
- Trans-Signaling Is a Dominant Mechanism for the Pathogenic Actions of Interleukin-6 in the Brain
- (2014) I. L. Campbell et al. JOURNAL OF NEUROSCIENCE
- Glycoprotein 130 polymorphism predicts soluble glycoprotein 130 levels
- (2014) Anna Wonnerth et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Signaling by IL-6 promotes alternative activation of macrophages to limit endotoxemia and obesity-associated resistance to insulin
- (2014) Jan Mauer et al. NATURE IMMUNOLOGY
- IL-6 biology: implications for clinical targeting in rheumatic disease
- (2014) Leonard H. Calabrese et al. Nature Reviews Rheumatology
- Anti-IL-6 Treatment for Inflammatory Bowel Diseases: Next Cytokine, Next Target
- (2013) Mariangela Allocca et al. CURRENT DRUG TARGETS
- IL-6 and its receptors in coronary artery disease and acute myocardial infarction
- (2013) Daniel R. Anderson et al. CYTOKINE
- Interleukin-6: From basic biology to selective blockade of pro-inflammatory activities
- (2013) Jürgen Scheller et al. SEMINARS IN IMMUNOLOGY
- Functional IL6R 358Ala Allele Impairs Classical IL-6 Receptor Signaling and Influences Risk of Diverse Inflammatory Diseases
- (2013) Ricardo C. Ferreira et al. PLoS Genetics
- Soluble Glycoprotein 130 Predicts Fatal Outcomes in Chronic Heart Failure
- (2012) Erik Tandberg Askevold et al. Circulation-Heart Failure
- Proinflammatory Cytokine Activation Is Linked to Apoptotic Mediator, Soluble Fas Level in Patients With Chronic Heart Failure
- (2012) Toru Kinugawa et al. International Heart Journal
- IL-6 Controls the Innate Immune Response against Listeria monocytogenes via Classical IL-6 Signaling
- (2012) J. Hoge et al. JOURNAL OF IMMUNOLOGY
- Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies
- (2012) LANCET
- The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis
- (2012) LANCET
- Transsignaling of Interleukin-6 Crucially Contributes to Atherosclerosis in Mice
- (2011) Harald Schuett et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Selective blockade of interleukin-6 trans-signaling improves survival in a murine polymicrobial sepsis model*
- (2011) Tanja Barkhausen et al. CRITICAL CARE MEDICINE
- Plasma soluble gp130 levels are increased in older subjects with metabolic syndrome. The role of insulin resistance
- (2010) Giovanni Zuliani et al. ATHEROSCLEROSIS
- The soluble Interleukin 6 receptor: Generation and role in inflammation and cancer
- (2010) Athena Chalaris et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- Genetic Loci Associated With C-Reactive Protein Levels and Risk of Coronary Heart Disease
- (2009) Paul Elliott JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Correlation of soluble gp130 serum concentrations with arterial blood pressure
- (2009) Ioana Inta et al. JOURNAL OF HYPERTENSION
- Essential Roles of IL-6 Trans-Signaling in Colonic Epithelial Cells, Induced by the IL-6/Soluble-IL-6 Receptor Derived from Lamina Propria Macrophages, on the Development of Colitis-Associated Premalignant Cancer in a Murine Model
- (2009) S. Matsumoto et al. JOURNAL OF IMMUNOLOGY
- Genetically Elevated C-Reactive Protein and Ischemic Vascular Disease
- (2008) Jeppe Zacho et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Polymorphism at the IL6ST (gp130) Locus Is Associated With Traits of the Metabolic Syndrome
- (2008) Lucia Gottardo et al. Obesity
- A non-conservative polymorphism in the IL-6 signal transducer (IL6ST)/gp130 is associated with myocardial infarction in a hypertensive population
- (2007) Anna Benrick et al. REGULATORY PEPTIDES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation